Related Experiment Video
Updated: Feb 6, 2026

Sex Differences in Mouse Hippocampal Astrocytes after In-Vitro Ischemia
Published on: October 25, 2016
Sex-specific differences in cardiac maladaptation to hypertension and arterial stiffening
Nicholas Cauwenberghs, Tatiana Kuznetsova1
1Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium. tatiana.kouznetsova@med.kuleuven.be.
Insights
Heart failure (HF) affects men and women similarly, but women are more prone to HF with preserved ejection fraction. Hypertension and arterial stiffness are key risk factors contributing to these sex differences in cardiac conditions.
Area of Science:
- Cardiology
- Cardiovascular Disease
- Hypertension Research
Background:
- Symptomatic heart failure (HF) prevalence is comparable between sexes, representing a significant portion of initial cardiovascular disease diagnoses.
- A notable sex-based divergence exists in HF subtypes: men more commonly present with HF with reduced ejection fraction, while women disproportionately develop HF with preserved ejection fraction.
Purpose of the Study:
- To review current epidemiological data on sex-based disparities in cardiac maladaptation.
- To explore the differing manifestations of heart failure (HF) in men and women.
- To examine the roles of hypertension and arterial stiffness in sex-specific HF development.
Main Methods:
- Literature review of epidemiological studies.
- Analysis of sex differences in heart failure prevalence and subtypes.
- Examination of the impact of hypertension and arterial stiffness on cardiac structure and function.
Main Results:
- Overall prevalence of symptomatic heart failure (HF) is similar in men and women.
- Women exhibit a higher frequency of HF with preserved ejection fraction compared to men.
- Men are more frequently diagnosed with HF with reduced ejection fraction.
- High blood pressure and arterial stiffness are identified as major risk factors for HF in both sexes.
Conclusions:
- Significant sex discrepancies exist in the type of heart failure (HF) developed, despite similar overall prevalence.
- Hypertension and arterial stiffness contribute to sex-specific cardiac maladaptations leading to HF.
- Further research into sex-specific mechanisms is crucial for targeted prevention and treatment strategies for heart failure.
Abstract:
The overall prevalence of symptomatic heart failure (HF) is similar in men and women and constitutes about a quarter of the first manifestation of cardiovascular disease in both sexes. However, there is an important difference between the sexes in the type of HF. Whereas men more frequently develop HF with reduced ejection fraction, HF with preserved ejection fraction is especially frequent in women. The major risk factors for symptomatic HF are high blood pressure and arterial stiffness, which evoke a complex network of functional and structural changes in the heart in both men and women. In this review, we will discuss the recent epidemiological data on sex discrepancies in cardiac maladaptation to hypertension and arterial stiffening.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Sex-linked Disorders
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

